Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
An Elevance Health director paid $366K out of pocket for Elevance Health shares. 1 other person at Elevance Health bought some too, in the same month. Shares held went up 10% with this purchase.
4 open-market purchases and 19 open-market sales by insiders of ELV between Dec 29, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 21, 2026. The data provider lists the next release for Jan 26, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Ratnakar Lavu, EVP & Chief Digital Info Ofr, Nov 5, 2026, about $572K. Sold 15 days after the company's previous earnings release on 2026-10-21Form 4
Mark Kaye, EVP & CFO, Oct 22, 2026, about $174K. Sold 1 day after the company's previous earnings release on 2026-10-21Form 4
Mark Kaye, EVP & CFO, Oct 22, 2026, about $140K. Sold 1 day after the company's previous earnings release on 2026-10-21Form 4
Mark Kaye, EVP & CFO, Oct 22, 2026, about $724K. Sold 1 day after the company's previous earnings release on 2026-10-21Form 4
, EVP & CFO, Oct 22, 2026, about $245K. Sold 1 day after the company's previous earnings release on 2026-10-21
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies